In particular, nonalcoholic steatohepatitis (NASH)-derived HCCs were shown to be less responsive to ICIs, probably due to the aberrant activation of CD8+ T cells causing tissue damage and impaired immune surveillance [9]. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.